Clay Siegall is a man on a mission. HIs mission is to revolutionize cancer research and aid those who have been diagnosed with this disease that claims millions of lives every year. To bring his aim into fruition, Clay founded Seattle Genetics and currently serves as the President of the company. With his business, Clay has had an enormous impact on the field of medicine, and with the revolutionary treatment that the business is working towards setting in place.
The idea to form his company came from the experiences that Clay Siegall had to witness in his childhood. When he was 19, his father was diagnosed with cancer. However, during that time, there were no proper tools to be able to equip doctors with the necessities to treat their patients. Watching this happen to a family member, Clay then decided to focus on oncological research, and to help better equip doctors to treat patients who are diagnosed with cancer. With the organization’s current research, doctors are now already being able to better read into the kind of cancer that their patients have, and are now able to give them a course of treatment that is best suited to their current state and illness progression.
Before he founded Seattle Genetics, Clay worked with the Bristol-Myers Squibb Washington University, where he studied the genetic composition of cancerous cells, which led him to one day starting up his company based on the very same research. Clay has also collaborated with numerous corporations and hospitals to aid his research better and help people who are in need of a proper course of treatment for their cancer. He wants to change the way cancer is treated, so as to make it better and more efficient.
Through his career, Clay has interacted with numerous people who have all contributed to his growth and development as the leader he is today. He believes in always taking some values from the people he looks up to add to his professional life. Using all that he has learned, he has led Seattle Genetics to a favorable direction, making it a leading organization for cancer research.